Platelet derived growth factor BB is a ligand for dermatan sulfate chain(s) of small matrix proteoglycans from normal and fibrosis affected fascia

Biochimie

Volumn 91, Issue 11-12, 2009, Pages 1394-1404

  Koźma, Ewa M ^a   Wisowski, Grzegorz ^a   Olczyk, Krystyna ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Dermatan sulfate; Dupuytren's fascia; Normal fasciae; Platelet derived growth factor

Indexed keywords

BIGLYCAN; COLLAGEN TYPE 3; DECORIN; DERMATAN SULFATE; DISACCHARIDE; FIBRONECTIN; GLUCURONIC ACID; HEXURONIC ACID; IDURONIC ACID; N ACETYLGALACTOSAMINE; PLATELET DERIVED GROWTH FACTOR BB; PROTEOGLYCAN;

ADULT; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; COVALENT BOND; DUPUYTREN CONTRACTURE; EPIMERIZATION; FASCIA LATA; FEMALE; FIBROSIS; HUMAN; HUMAN TISSUE; ISOMER; MALE; PALMAR FASCIA; PROTEIN PROTEIN INTERACTION; SULFATION;

DERMATAN SULFATE; FASCIA; FEMALE; FIBROSIS; HUMANS; MALE; MIDDLE AGED; PHOSPHATIDYLGLYCEROLS; PLATELET-DERIVED GROWTH FACTOR; PROTEOGLYCANS; SERUM ALBUMIN, BOVINE;

EID: 72649089542     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2009.07.010     Document Type: Article

References (33)

1. Hoch R.V., and Soriano P. Roles of PDGF in animal development. Development 130 (2003) 4769-4784
2. Heldin C.H., and Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79 (1999) 1283-1316
3. Andrae J., Gallini R., and Betsholtz Ch. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 22 (2008) 1276-1312
4. Lindblom P., Gerhardt H., Liebner S., et al. Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev. 17 (2003) 1835-1840
5. Rayan G.M. Clinical presentation and types of Dupuytren's disease. Hand Clin. 15 (1999) 87-96
6. Terek R.M., Jiranek W.A., Goldberg M.J., Wolfe H.J., and Alman B.A. The expression of platelet-derived growth-factor gene in Dupuytren contracture. J. Bone Joint Surg. Am. 77 (1995) 1-9
7. Badalamente M.A., Hurst L.C., Grandia S.K., and Sampson S.P. Platelet-derived growth factor in Dupuytren's disease. J. Hand Surg. Am. 17 (1992) 317-323
8. Raines E.W., and Ross R. Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences. J. Cell Biol. 116 (1992) 533-542
9. Abramsson A., Kurup S., Busse M., et al. Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development. Genes Dev. 21 (2007) 316-331
10. Rolny Ch., Spillmann D., Lindahl U., and Claesson-Welsh L. Heparin amplifies platelet-derived growth factor (PDGF)-BB-induced PDGF α-receptor but not PDGF β-receptor tyrosine phosphorylation in heparin sulfate-deficient cells. J. Biol. Chem. 277 (2002) 19315-19321
11. Malmström J., and Westergren-Thorsson G. Heparan sulfate upregulates platelet-derived growth factor receptors on human lung fibroblasts. Glycobiology 8 (1998) 1149-1155
12. Li L., Heldin C.H., and Heldin P. Inhibition of plateled-derived growth factor-BB-induced receptor activation and fibroblast migration by hyaluronan activation of CD44. J. Biol. Chem. 281 (2006) 26512-26519
13. Prydz K., and Dalen K.T. Synthesis and sorting of proteoglycans. J. Cell Sci. 113 (2000) 193-205
14. Koźma E.M., Olczyk K., Wisowski G., Głowacki A., and Bobiński R. Alterations in the extracellular matrix proteoglycan profile in Dupuytren's contracture affect the palmar fascia. J. Biochem. 137 (2005) 468-476
15. Garcia-Olivas R., Hoebeke J., Castel S., et al. Differential binding of platelet-derived growth factor isoforms to glycosaminoglycans. Histochem. Cell Biol. 120 (2003) 371-382
16. Rombouts J.J., Noel H., Legrain Y., and Munting E. Prediction of recurrence in the treatment of Dupuytren's disease: evaluation of a histologic classification. J. Hand Surg. 14 (1989) 644-652
17. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
18. Farndale R.W., Buttle D.J., and Barrett A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim. Biophys. Acta 883 (1986) 173-177
19. Koźma E.M., Olczyk K., Głowacki A., and Bobiński R. An accumulation of proteoglycans in scarred fascia. Mol. Cell. Biochem. 203 (2000) 103-112
20. Deakin J.A., and Lyon M. A simplified and sensitive fluorescent method for disaccharide analysis of both heparin sulfate and chondroitin/dermatan sulfates from biological samples. Glycobiology 18 (2008) 483-491
21. Lyon M., and Gallagher J.T. A general method for the detection and mapping of submicrogram quantities of glycosaminoglycan oligosaccharides on polyacrylamide gels by sequential staining with azure A and ammoniacal silver. Anal. Biochem. 185 (1990) 63-70
22. Koźma E.M., Olczyk K., and Głowacki A. Dermatan sulfates of normal and scarred fascia. Comp. Biochem. Physiol. B 128 (2001) 221-232
23. Hedbom E., and Heinegard D. Interaction of a 59-kDa connective tissue matrix protein with collagen I and collagen II. J. Biol. Chem. 264 (1989) 6898-6905
24. Lyon M., Deakin J.A., Rahmoune H., Fernig D.G., Nakamura T., and Gallagher J.T. Hepatocyte growth factor/scatter factor binds with high affinity to dermatan sulphate. J. Biol. Chem. 273 (1998) 271-278
25. Taylor K.R., Rudisill J.A., and Gallo R.L. Structural and sequence motifs in dermatan sulfate for promoting fibroblast growth factor-2 (FGF-2) and FGF-7 activity. J. Biol. Chem. 280 (2005) 5300-5306
26. Catlow K.R., Deakin J.A., Wei Z., et al. Interactions of hepatocyte growth factor/scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulfate density. J. Biol. Chem. 283 (2008) 5235-5248
27. Silbert J.E., and Sugumaran G. Biosynthesis of chondroitin/dermatan sulphate. IUBMB Life 54 (2002) 177-186
28. Lustig F., Hoebeke J., Simonson C., et al. Processing of PDGF gene products determines interactions with glycosaminoglycans. J. Mol. Recognit. 12 (1999) 112-120
29. Schilling D., Reid IV J.D., Hujer A., et al. Loop III region of platelet-derived growth factor (PDGF) B-chain mediates binding to PDGF receptors and heparin. Biochem. J. 333 (1998) 637-644
30. Griffin M., and Bergamini C.M. Transglutaminases: nature's biological glues. Biochem. J. 368 (2002) 377-396
31. Dolynchuk K.N., and Pettigrew N.M. Transglutaminase levels in Dupuytren's disease. J. Hand Surg. Am. 16 (1991) 787-790
32. Somasundaram R., and Schuppan D. Type I, II, III, V, and VI collagens serve as extracellular ligands for the isoforms of platelet-derived growth factor (AA, BB, and AB). J. Biol. Chem. 271 (1996) 26884-26891
33. Nili N., Cheema A.N., Giordano F.J., et al. Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function. Am. J. Pathol. 163 (2003) 869-878